{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:15:52Z","timestamp":1792678552658,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,24]]},"DOI":"10.7759\/cureus.81085","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T19:35:38Z","timestamp":1742844938000},"source":"Crossref","is-referenced-by-count":1,"title":["A Series of Glomerular Diseases That Developed After COVID-19 Vaccination"],"prefix":"10.7759","author":[{"given":"Yukako","family":"Umezawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatsugu","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13037-021-00291-9","article-title":"Review the safety of COVID-19 mRNA vaccines: a review","volume":"15","author":"Anand P","year":"2021","unstructured":"Anand P, Stahel VP. Review the safety of COVID-19 mRNA vaccines: a review. Patient Saf Surg. 2021, 15:20. 10.1186\/s13037-021-00291-9","journal-title":"Patient Saf Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices - United States, June 2021","volume":"70","author":"Gargano JW","year":"2021","unstructured":"Gargano JW, Wallace M, Hadler SC, et al.. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021, 70:977-82. 10.15585\/mmwr.mm7027e2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004957","article-title":"Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination","volume":"5","author":"Portuguese AJ","year":"2021","unstructured":"Portuguese AJ, Sunga C, Kruse-Jarres R, Gernsheimer T, Abkowitz J. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Adv. 2021, 5:2794-8. 10.1182\/bloodadvances.2021004957","journal-title":"Blood Adv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.09.008","article-title":"COVID-19 vaccination and glomerulonephritis","volume":"6","author":"Klomjit N","year":"2021","unstructured":"Klomjit N, Alexander MP, Fervenza FC, et al.. COVID-19 vaccination and glomerulonephritis. Kidney Int Rep. 2021, 6:2969-78. 10.1016\/j.ekir.2021.09.008","journal-title":"Kidney Int Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103340","article-title":"Insights into new-onset autoimmune diseases after COVID-19 vaccination","volume":"22","author":"Guo M","year":"2023","unstructured":"Guo M, Liu X, Chen X, Li Q. Insights into new-onset autoimmune diseases after COVID-19 vaccination. Autoimmun Rev. 2023, 22:103340. 10.1016\/j.autrev.2023.103340","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz176","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective","volume":"36","author":"Bridoux F","year":"2021","unstructured":"Bridoux F, Javaugue V, Nasr SH, Leung N. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective. Nephrol Dial Transplant. 2021, 36:208-15. 10.1093\/ndt\/gfz176","journal-title":"Nephrol Dial Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.05.004","article-title":"The clinical and histopathological feature of renal manifestation of TAFRO syndrome","volume":"5","author":"Mizuno H","year":"2020","unstructured":"Mizuno H, Sawa N, Watanabe S, et al.. The clinical and histopathological feature of renal manifestation of TAFRO syndrome. Kidney Int Rep. 2020, 5:1172-9. 10.1016\/j.ekir.2020.05.004","journal-title":"Kidney Int Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-013-0849-x","article-title":"Proposal of remission criteria for IgA nephropathy","volume":"18","author":"Suzuki Y","year":"2014","unstructured":"Suzuki Y, Matsuzaki K, Suzuki H, et al.. Proposal of remission criteria for IgA nephropathy. Clin Exp Nephrol. 2014, 18:481-6. 10.1007\/s10157-013-0849-x","journal-title":"Clin Exp Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US From December","volume":"327","author":"Oster ME","year":"2022","unstructured":"Oster ME, Shay DK, Su JR, et al.. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US From December. JAMA. 2022, 327:331-40. 10.1001\/jama.2021.24110","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen Y","year":"2022","unstructured":"Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, Pan HF. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022, 165:386-401. 10.1111\/imm.13443","journal-title":"Immunology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.06.002","article-title":"Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine","volume":"100","author":"Masset C","year":"2021","unstructured":"Masset C, Kervella D, Kandel-Aznar C, Fantou A, Blancho G, Hamidou M. Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine. Kidney Int. 2021, 100:465-6. 10.1016\/j.kint.2021.06.002","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.017","article-title":"ANCA glomerulonephritis after the Moderna COVID-19 vaccination","volume":"100","author":"Sekar A","year":"2021","unstructured":"Sekar A, Campbell R, Tabbara J, Rastogi P. ANCA glomerulonephritis after the Moderna COVID-19 vaccination. Kidney Int. 2021, 100:473-4. 10.1016\/j.kint.2021.05.017","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.08.006","article-title":"Membranous nephropathy following anti-COVID-19 mRNA vaccination","volume":"100","author":"Gueguen L","year":"2021","unstructured":"Gueguen L, Loheac C, Saidani N, Khatchatourian L. Membranous nephropathy following anti-COVID-19 mRNA vaccination. Kidney Int. 2021, 100:1140-1. 10.1016\/j.kint.2021.08.006","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/7292895","article-title":"A case of TAFRO syndrome developed after COVID-19 vaccination","volume":"2023","author":"Hirose H","year":"2023","unstructured":"Hirose H, Suzuki H, Umezawa Y, et al.. A case of TAFRO syndrome developed after COVID-19 vaccination. Case Rep Nephrol. 2023, 2023:7292895. 10.1155\/2023\/7292895","journal-title":"Case Rep Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.09.002","article-title":"COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?","volume":"100","author":"Li NL","year":"2021","unstructured":"Li NL, Coates PT, Rovin BH. COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?. Kidney Int. 2021, 100:959-65. 10.1016\/j.kint.2021.09.002","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000523962","article-title":"New onset biopsy-proven nephropathies after COVID vaccination","volume":"53","author":"Fenoglio R","year":"2022","unstructured":"Fenoglio R, Lalloni S, Marchisio M, et al.. New onset biopsy-proven nephropathies after COVID vaccination. Am J Nephrol. 2022, 53:325-30. 10.1159\/000523962","journal-title":"Am J Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-022-02299-6","article-title":"Association between COVID-19 vaccination and relapse of glomerulonephritis","volume":"27","author":"Ota Y","year":"2023","unstructured":"Ota Y, Kuroki R, Iwata M, et al.. Association between COVID-19 vaccination and relapse of glomerulonephritis. Clin Exp Nephrol. 2023, 27:236-42. 10.1007\/s10157-022-02299-6","journal-title":"Clin Exp Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9111252","article-title":"New-onset and relapsed kidney histopathology following COVID-19 vaccination: a systematic review","volume":"9","author":"Wu HH","year":"2021","unstructured":"Wu HH, Kalra PA, Chinnadurai R. New-onset and relapsed kidney histopathology following COVID-19 vaccination: a systematic review. Vaccines (Basel). 2021, 9:1252. 10.3390\/vaccines9111252","journal-title":"Vaccines (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/335753-a-series-of-glomerular-diseases-that-developed-after-covid-19-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T19:35:41Z","timestamp":1742844941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/335753-a-series-of-glomerular-diseases-that-developed-after-covid-19-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.81085","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,24]]}}}